The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Schizophrenia Research

• Publication date

  2009-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2009.08.016PMID 19766459PMCID PMC2765056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Social Cognition Training for Individuals with Schizophrenia: Emerging Evidence

  2008cited by this paper
• Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial

  2008cited by this paper
• The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.

  2008cited by this paper
• Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

  2007influential reference
• Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.

  2007cited by this paper
• Social Cognition and Neurocognition: Effects of Risperidone, Olanzapine, and Haloperidol.

  2007influential reference
• Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol.

  2007cited by this paper
• Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

  2006cited by this paper
• Behavioral Rehabilitation of the "Treatment-Refractory" Schizophrenia Patient: Conceptual Foundations, Interventions, and Outcome Data

  2006cited by this paper
• Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.

  2006influential reference
• Strategies for coping with cognitive impairments of clients in supported employment.

  2006cited by this paper
• Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia.

  2006cited by this paper
• The American Psychiatric Publishing Textbook of Schizophrenia

  2006cited by this paper
• The American Psychiatric Publishing Textbook of Schizophrenia

  2006cited by this paper
• The functional significance of social cognition in schizophrenia: a review.

  2006cited by this paper
• Social Cognitive Impairments.

  2006cited by this paper
• Cognitive remediation and vocational rehabilitation for schizophrenia.

  2005cited by this paper
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cited by this paper
• Cognitive training and supported employment for persons with severe mental illness: one-year results from a randomized controlled trial.

  2005cited by this paper
• Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

  2005influential reference
• Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia.

  2005cited by this paper
• Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model.

  2004cited by this paper
• Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine.

  2004cited by this paper
• Effectiveness of a two-phase cognitive rehabilitation intervention for severely impaired schizophrenia patients

  2004cited by this paper
• Recognition of facial emotions in schizophrenia

  2004cited by this paper
• The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.

  2003influential reference
• Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.

  2003cited by this paper
• Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies.

  2003cited by this paper
• Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review.

  2002cited by this paper
• Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment.

  2001cited by this paper
• The neurobiology of social cognition.

  2001cited by this paper
• Modification of affect perception deficits in schizophrenia.

  2000cited by this paper
• The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

  1999cited by this paper
• Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings.

  1998cited by this paper
• Handbook of Social Functioning in Schizophrenia

  1998cited by this paper
• Facial expressions of emotions and schizophrenia: a review.

  1998cited by this paper
• Structured clinical interview for DSM-IV axis I disorders : SCID-I: clinical version : administration booklet

  1997cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Social cognition in schizophrenia.

  1997cited by this paper
• Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance?

  1993influential reference

• Social cognition training improves recognition of individual emotions in schizophrenia disorder

  2025cites this paper
• Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis.

  2025cites this paper
• The role of metacognition and social cognition in childhood trauma effecting on prognosis: 1-year follow-up study in patients with first-episode schizophrenia

  2025cites this paper
• Quantifying abnormal emotion processing: A novel computational assessment method and application in schizophrenia.

  2024cites this paper
• Social cognition across the schizophrenia–bipolar disorder spectrum

  2024cites this paper
• Impaired emotion perception in schizophrenia shows sex differences with channel- and category-specific effects: A pilot study.

  2023cites this paper
• Training volitional control of the theory of mind network with real-time fMRI neurofeedback

  2023cites this paper
• Specific facial emotion recognition deficits across the course of psychosis: A comparison of individuals with low-risk, high-risk, first-episode psychosis and multi-episode schizophrenia-spectrum disorders.

  2022cites this paper
• Neuroimaging oxytocin modulation of social reward learning in schizophrenia

  2022cites this paper
• Social cognition training improves recognition of distinct facial emotions and decreases misattribution errors in healthy individuals

  2022cites this paper
• Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective

  2022influential citation
• Neural correlates of emotional processing in psychosis risk and onset – A systematic review and meta-analysis of fMRI studies

  2021cites this paper
• Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation Program

  2021cites this paper
• A systematic review of the effects of psychiatric medications on social cognition

  2021cites this paper
• Oxytocin effects on eye movements in schizophrenia

  2021influential citation
• The importance of pro-social processing, and ameliorating dysfunction in schizophrenia. An FMRI study of oxytocin

  2021cites this paper
• Title: The Effect of Antipsychotics on the Cognitive Performance of Individuals with Psychotic Disorders: Network Meta-Analyses of Randomized Controlled Trials.

  2021cites this paper
• Case of Asperger's Syndrome and Lesion of the Right Amygdala: Deficits in Implicit and Explicit Fearful Face Recognition

  2021cites this paper
• Self-assessment of social cognition in a sample of Lebanese in-patients with schizophrenia

  2021cites this paper
• Does clozapine improves cognition in patients with treatment resistant schizophrenia?: An exploratory study.

  2020cites this paper
• In the eye of the beholder? Oxytocin effects on eye movements in schizophrenia.

  2019cites this paper
• Difficulties in emotion regulation and symptom dimensions in patients with obsessive-compulsive disorder

  2018cites this paper
• The Importance of Social Cognition in Improving Functional Outcomes in Schizophrenia

  2018cites this paper
• The use of the Duchenne marker and symmetry of the expression in the judgment of smiles in schizophrenia.

  2017cites this paper
• An investigation of social cognition using psilocybin and MDMA

  2017cites this paper
• The neuroimaging and genetics of emotion perception in schizophrenia

  2017cites this paper
• A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.

  2017cites this paper
• Exploring social cognition and mirror systems in schizophrenia and bipolar disorder

  2017cites this paper
• Treatment of social cognition in schizophrenia: Current status and future directions.

  2017cites this paper
• Reversal of social deficits by subchronic oxytocin in two autism mouse models.

  2016cites this paper
• Restricted attention to social cues in schizophrenia patients

  2016cites this paper
• Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior

  2016cites this paper
• Reduced mu suppression and altered motor resonance in euthymic bipolar disorder: Evidence for a dysfunctional mirror system?

  2016cites this paper
• Emotional Processing among Schizophrenia: Implication for Further Management

  2016cites this paper
• The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial

  2016cites this paper
• Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials

  2016cites this paper
• Reward modulates the mirror neuron system in schizophrenia: A study into the mu rhythm suppression, empathy, and mental state attribution

  2016cites this paper
• Emotional Intelligence deficits in schizophrenia: The impact of non-social cognition.

  2016cites this paper
• Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment

  2015cites this paper
• Perphenazine for schizophrenia.

  2015cites this paper
• Prosodic and semantic affect perception in remitted patients with bipolar I disorder.

  2015cites this paper
• Emotion processing in schizophrenia is state and trait dependent.

  2015cites this paper
• Facial emotion recognition and sleep in mentally disordered patients: A natural experiment in a high security hospital.

  2015cites this paper
• Personality trait correlates of color preference in schizophrenia

  2015cites this paper
• Mirror systems in schizophrenia 1 No evidence for mirror system dysfunction in schizophrenia from a multimodal TMS / EEG study

  2015cites this paper
• Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia

  2015cites this paper
• Prévention de l’hétéro-agressivité des sujets schizophrènes : efficacité des antipsychotiques de première et de seconde génération

  2015cites this paper
• Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects

  2015influential citation
• Multimodale Integration bei Menschen mit erhöhtem Psychoserisiko

  2015cites this paper
• Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia.

  2015cites this paper
• A randomized, controlled trial of Social Cognition and Interaction Training (SCIT) for outpatients with schizophrenia spectrum disorders.

  2014cites this paper
• Affective prosody perception in symptomatically remitted patients with schizophrenia and bipolar disorder.

  2014cites this paper
• Biases in facial and vocal emotion recognition in chronic schizophrenia

  2014cites this paper
• Evolutionary perspectives on the role of oxytocin in human social behavior, social cognition and psychopathology.

  2014cites this paper
• Schizophrenia and alcohol dependence: diverse clinical effects of oxytocin and their evolutionary origins.

  2014cites this paper
• Facial emotion identification in early-onset psychosis.

  2014cites this paper
• An Overview of Social Cognitive Treatment Interventions

  2014cites this paper
• Advancing rodent models of the behaviours and the neurobiological pathology associated with schizophrenia

  2014cites this paper
• A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia.

  2014cites this paper
• Repetitive Transcranial Magnetic Stimulation (rTMS) Improves Facial Affect Recognition in Schizophrenia

  2014cites this paper
• Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia.

  2013cites this paper
• Social cognition and interaction training for patients with stable schizophrenia in Chinese community settings.

  2013cites this paper
• Symptom Correlates of Facial Emotion Recognition Impairment in Schizophrenia

  2013cites this paper
• Can Antipsychotics Improve Social Cognition in Patients with Schizophrenia?

  2013cites this paper
• Metakognitive und sozial-kognitive Defizite bei Schizophrenien. Funktionelle Bedeutung und Behandlungsstrategien

  2013cites this paper
• Prospective and concurrent correlates of emotion perception in psychotic disorders: a naturalistic, longitudinal study of neurocognition, affective blunting and avolition.

  2013cites this paper
• Synergistic Effects of COMT and TPH2 on Social Cognition

  2013cites this paper
• Antipsychotics: A General View of Therapeutic and Adverse Effects

  2013cites this paper
• The Health Benefits and Challenges of Exercise Training in Persons Living with Schizophrenia: A Pilot Study

  2013cites this paper
• Effectiveness of paliperidone extended‐release for patients with schizophrenia: focus on subjective improvement

  2013cites this paper
• Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.

  2013cites this paper
• Emotion recognition impairment is present early and is stable throughout the course of schizophrenia.

  2013cites this paper
• Quetiapine versus other atypical antipsychotics for schizophrenia.

  2013cites this paper
• Impact of family involvement on social cognition training in clinically stable outpatients with schizophrenia -- a randomized pilot study.

  2012cites this paper
• Face emotion processing deficits in schizophrenia: identification and remediation utilising visual scanpath technology

  2012cites this paper
• An investigation of the effects of oxytocin on social cognition and social functioning in schizophrenia

  2012influential citation
• Social cognition and visual perception in schizophrenia inpatients treated with first-and second-generation antipsychotic drugs.

  2012cites this paper
• A meta-analysis of emotion perception and functional outcomes in schizophrenia.

  2012cites this paper
• Potential therapeutic avenues to tackle social cognition problems in schizophrenia

  2012cites this paper
• Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study.

  2012cites this paper
• Mentalizing Skills Deficits in Schizophrenia as a Clue for Drug Choice: Clozapine Versus Other Antipsychotics on Keeping Outpatients Stable

  2012cites this paper
• Schizophrenia and Social Cognition: From Conceptual Bases to Therapeutic Approaches

  2012cites this paper
• Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs

  2012cites this paper
• Effects of facial emotion recognition remediation on visual scanning of novel face stimuli.

  2012cites this paper
• Oxytocin in schizophrenia: a review of evidence for its therapeutic effects

  2012cites this paper
• Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study.

  2012cites this paper
• Alexithymia and Personality Disorder Functioning Styles in Paranoid Schizophrenia

  2011cites this paper
• Neurocognition, Social Cognition and Functional Outcome in Schizophrenia

  2011cites this paper
• Papel dos anti-psicóticos típicos vs atípicos na sintomatologia negativa da esquizofrenia

  2011influential citation
• Interventions Targeting Social and Vocational Dysfunction in Individuals with a Schizophrenia Spectrum Disorder

  2011cites this paper
• Attention shaping as a means to improve emotion perception deficits in outpatients with schizophrenia and impaired controls.

  2011cites this paper
• Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.

  2011cites this paper
• The effect of emotional context on facial emotion ratings in schizophrenia.

  2011cites this paper
• Clozapine versus other atypical antipsychotics for schizophrenia.

  2010cites this paper
• Effect of quetiapine treatment on facial emotion recognition deficits in schizophrenia patients.

  2010cites this paper
• Antipsychotic medication and social cue recognition in chronic schizophrenia.

  2010cites this paper
• Current awareness in human psychopharmacology

  2010cites this paper
• Social cognition: the key factor predicting social outcome in people with schizophrenia?

  2010cites this paper
• Social Cognition and Interaction Training (SCIT) for Individuals with Schizophrenia Spectrum Disorders in Outpatient Treatment Settings

  2010cites this paper
• Ziprasidone versus other atypical antipsychotics for schizophrenia.

  2009cites this paper